Antibody Discovery and Optimization Platform

Adimab is the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies.

The Adimab Platform is based on synthetic and natural immune repertoires that are propagated and screened in their proprietary yeast system. Its technology allows the selection of key antibody properties in real-time.